OTC · Financial Statements

BioInvent International AB (publ) (BOVNF) Financial Statements

$3.29 OTC: BOVNF Market Cap $216.40M

BioInvent International AB (publ) most recently reported annual revenue of $226.0M, net profit of $-332.0M, revenue has compounded at 9.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$19.0M$326.0M$71.0M$45.0M$226.0M
Operating Profit$-278.0M$-51.0M$-370.0M$-471.0M$-351.0M
Net Profit$-279.0M$-34.0M$-330.0M$-429.0M$-332.0M
EPS$-5.15$-0.55$-5.02$-6.53$-5.07
Op Margin-1436.0%-15.6%-517.7%-1054.2%-155.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.7B$1.4B$989.0M$670.0M
Total Liabilities$80.0M$106.0M$90.0M$103.0M$113.0M
Cash$911.0M$515.0M$260.0M$435.0M$355.0M
Borrowings$28.0M$27.0M$23.0M$17.0M$10.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-246.0M$-41.0M$-342.0M$-380.0M$-247.0M
Investing Cash Flow$-935.0M$-1.3B$46.0M$554.0M$172.0M
Financing Cash Flow$-6.0M$-6.0M$-8.0M$-8.0M$-9.0M
Net Cash Flow$181.0M$-396.0M$-255.0M$175.0M$-6.0M
Free Cash Flow$-259.0M$-54.0M$-355.0M$-391.0M$-254.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.24
EV / EBITDA-3.51
FCF Yield-17.75%
Quick Ratio5.20
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-30.03%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BOVNF Overview BOVNF Dividend Run Stock Screener